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Abstract	
	
Introduction:	People	with	mental	health	disorders	are	much	more	likely	to	smoke	compared	to	those	
without.	This	study	investigates	recent	trends	in	smoking	behaviours	in	both	these	populations	in	
England.	
	
Methods:	We	used	survey	responses	from	adults	(aged	16+)	living	in	households	in	England	who	
participated	in	the	Health	Survey	for	England	from	1993	to	2011	(n=11,300	per	year	on	average).		
Linear	regression	was	used	to	quantify	annual	changes	over	the	time	period	in	smoking	prevalence,	
daily	cigarette	consumption	and	desire	to	quit	in	respondents	with	and	without	two	indicators	of	
mental	disorder	(self-reported	longstanding	mental	illness	and	recent	use	of	psychoactive	
medication).	
	
Results:	Amongst	survey	respondents	who	did	not	report	a	longstanding	mental	illness	there	were	
long	term	declines	in	smoking	prevalence	(-0.48%	per	year,	95%	CI	-0.56	to	-0.40)	and	daily	cigarette	
consumption	(-0.14%	per	year,	95%	CI	-0.17	to	-0.11).	Similar	declines	were	also	seen	in	respondents	
not	taking	psychoactive	medications.	However,	there	were	no	long-term	changes	in	smoking	
prevalence	and	cigarette	consumption	in	respondents	who	reported	these	indicators	of	mental	
disorder,	though	smoking	prevalence	in	those	taking	psychoactive	medications	may	have	declined	in	
the	later	part	of	the	study	period.	Smokers	both	with	and	without	the	two	indicators	of	mental	
disorder	showed	similar	levels	of	desire	to	quit	smoking.	
	
Conclusions:	Smoking	is	largely	unchanged	since	1993	among	those	with	indicators	of	longstanding	
mental	disorders	or	recent	psychoactive	medication	usage,	although	declines	have	been	observed	in	
those	without	such	indicators	of	mental	disorder.	
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Introduction	
	
Smoking	prevalence	has	declined	in	many	countries	in	recent	years,	and	overall	mortality	from	
smoking-related	disease	is	now	falling	(Peto	et	al.,	2012).	However,	survey	data	consistently	
highlight	a	higher	smoking	prevalence	in	people	with	mental	health	disorders	(Coulthard	et	al.,	2002;	
Ziedonis	et	al.,	2008),	though	temporal	trends	in	prevalence	in	this	group	have	not	been	extensively	
studied.	In	one	study	from	the	United	States,	declines	in	smoking	prevalence	seen	in	the	general	
population	from	2004	to	2011	did	not	extend	to	those	with	indicators	of	mental	disorder	(Lê	Cook	et	
al.,	2014)	and	similar	findings	have	been	reported	amongst	adults	living	in	New	York	State	(New	York	
State	Department	of	Health,	2012).	Any	widening	of	the	prevalence	gap	between	people	with	and	
without	mental	disorders,	such	as	that	suggested	by	these	American	data,	will	increase	existing	
health	impacts	and	inequalities	(Brown,	Barraclough	&	Inskip,	2000;	Department	of	Health,	2011;	
Osborn	et	al.,	2007;	Parks	et	al.,	2006;	Ziedonis	et	al.,	2008).	This	paper	presents	data	from	the	
Health	Survey	for	England	(HSE)	to	describe	trends	over	time	in	smoking	behaviour	in	England	in	
people	who	do	and	do	not	report	having	a	longstanding	mental	disorder	or	that	they	are	taking	a	
psychoactive	medication.		
	
Methods	
	
The	HSE	is	a	repeated	annual	cross-sectional	household	survey	which	has	questioned	on	average	
11,300	adults	aged	16	and	over	in	England	each	year	since	1993	(range	4,610	–	16,551,	with	
interviews	taking	place	across	the	year).	The	survey	uses	a	multi-stage	stratified	random	sampling	
strategy	to	produce	nationally-representative	information	about	a	number	of	aspects	of	population	
health.	We	used	data	from	1993	to	2011	and	extracted	information	on	two	indicators	of	mental	
disorder.	Each	year,	respondents	were	asked	‘Do	you	have	any	long-standing	illness,	disability	or	
infirmity?	By	long-standing	I	mean	anything	that	has	troubled	you	over	a	period	of	time,	or	that	is	
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likely	to	affect	you	over	a	period	of	time?’	This	question	has	been	used	for	many	years	across	several	
UK	surveys,	with	respondents’	answers	categorised	into	major	illness	groups,	including	a	category	
termed	‘longstanding	mental	illness,	depression	or	anxiety’.	Secondly,	in	the	majority	of	years	since	
1995	HSE	respondents	have	been	asked	for	the	names	of	prescribed	medications	they	had	taken	
within	the	seven	days	prior	to	the	interview,	from	which	those	taking	psychoactive	treatments	
(antipsychotics,	mood	stabilisers,	antidepressants	and	anxiolytics)	were	identified.	Current	smokers,	
defined	as	those	who	responded	positively	to	the	question	‘Do	you	smoke	cigarettes	at	all	
nowadays?’	were	asked	how	many	cigarettes	they	consume	daily	and,	since	2000,	whether	they	
would	like	to	give	up	smoking	altogether.		
	
For	each	year,	smoking	prevalence	(with	95%	confidence	intervals,	CI)	was	calculated	separately	in	
four	subgroups	of	respondents:	smokers	reporting	having	a	longstanding	mental	illness;	smokers	not	
reporting	having	a	longstanding	illness;	smokers	reporting	taking	a	psychoactive	medication	at	the	
time	of	the	survey;	and	smokers	not	reporting	taking	a	psychoactive	medication	at	the	time	of	the	
survey.	In	smokers,	the	average	number	of	cigarettes	consumed	per	day	and	(since	2000)	the	
proportion	wanting	to	quit	smoking	altogether	was	calculated	for	each	group.		Linear	regression	was	
used	to	quantify	the	temporal	trend	in	each	outcome	measure	in	each	subgroup	over	the	study	
period.	All	analyses	accounted	for	the	survey	sampling	design	and	participant	non-response.	
	
HSE	data	were	obtained	from	the	Economic	and	Social	Data	Service	and	no	additional	ethical	
approval	was	required	for	their	use.	All	analyses	were	carried	out	using	STATA	12.0	(STATA	Corp,	
College	Station,	TX).	
	
Results	
	
Prevalence	of	mental	health	problems	over	time	
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The	proportion	of	survey	respondents	reporting	a	longstanding	mental	health	condition	increased	
gradually	from	1.7%	in	1993	(95%	CI	1.5-1.9)	to	3.8%	in	2011	(95%	CI	3.3-4.2%).	Similarly,	an	increase	
was	also	observed	in	the	proportion	of	respondents	who	reported	taking	a	psychoactive	medication	
at	the	time	of	the	survey,	from	3.8%	in	1995	(95%	CI	3.5-4.1)	to	5.5%	in	2011	(95%	CI	5.0-6.1).	There	
was	some	overlap	between	the	two	measures	of	mental	disorder.	In	2011,	for	example,	91.9%	of	
respondents	reported	neither	indicator,	2.0%	reported	both,	49.0%	of	respondents	reporting	a	
longstanding	mental	health	condition	also	reported	recent	use	of	a	psychoactive	drug	and	32.1%	of	
respondents	reporting	taking	a	psychoactive	drug	also	reported	a	longstanding	mental	health	
condition.		
	
Smoking	prevalence	and	cigarette	consumption	over	time	
Figure	1	illustrates	the	temporal	changes	observed	in	smoking	prevalence	and	cigarette	consumption	
for	respondents	with	and	without	a	longstanding	mental	health	condition	and	who	were	and	were	
not	taking	a	psychoactive	medication.	Table	1	presents	the	results	of	linear	regression	showing	the	
average	annual	decline	in	each	measure	of	smoking	behaviour	over	the	time	period	for	which	data	
were	available.	
	
The	comparatively	small	number	of	HSE	respondents	reporting	a	longstanding	mental	health	
condition	(324	per	year	on	average)	or	recent	psychoactive	drug	use	(502	per	year)	results	in	
relatively	large	confidence	intervals	around	the	population	estimates	of	smoking	prevalence	and	
cigarette	consumption.	However,	inspection	of	Figure	1	and	Table	1	suggests	that	smoking	
prevalence	and	average	daily	cigarette	consumption	have	declined	steadily	over	time	in	respondents	
without	each	indicator	of	mental	disorder,	but	that	there	has	been	little	change	in	those	who	report	
a	longstanding	mental	health	condition	or	who	report	taking	a	psychoactive	medication.		
Though	a	significant	annual	change	in	smoking	prevalence	in	patients	taking	a	psychoactive	
medication	is	reported	in	Table	1,	inspection	of	Figure	1	suggests	that	the	decline	may	only	have	
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occurred	towards	the	end	of	the	time	series	and	indeed	the	regression	coefficient	for	the	trend	over	
time	excluding	the	last	two	years’	of	data	is	non-significant.	Smoking	prevalence	may	perhaps	have	
started	to	decline	in	2010	in	both	indicators	of	mental	disorder,	with	a	small	upturn	in	2011,	though	
further	surveys	are	needed	to	confirm	any	trend.	
	
Changes	in	desire	to	quit	over	time	
The	proportion	of	smokers	with	and	without	a	longstanding	mental	illness	who	report	wanting	to	
quit	shows	no	upwards	or	downwards	trend	over	time.	Similarly,	there	was	no	significant	change	
over	time	in	the	proportion	of	smokers	who	are/are	not	taking	a	psychoactive	medication	who	
report	wanting	to	quit.	
	
As	supplementary	data,	available	online	only,	we	present	results	of	analysis	in	respondents	with	
both	indicators	and	neither	indicator	of	mental	disorder.	These	results	are	in	line	with	the	data	
presented	above,	showing	a	statistically	significant	long	term	decline	in	smoking	prevalence	and	
daily	consumption	in	smokers	with	neither	indicator	of	mental	disorder,	no	significant	trend	in	those	
with	both	indicators,	and	no	change	over	time	in	desire	to	quit	in	both	groups.	
	
Discussion	
	
The	HSE	data	presented	here	show	long-term	declines	in	smoking	prevalence	and	average	daily	
cigarette	consumption	in	people	who	do	not	report	having	a	longstanding	mental	health	condition	
or	taking	psychoactive	medication,	but	no	decline	in	those	with	these	indicators	of	mental	disorder,	
with	the	exception	of	a	possible	recent	decline	in	prevalence	in	people	taking	a	psychoactive	
medication.	As	a	result,	smoking-related	health	inequalities	have	arguably	increased	between	these	
groups,	despite	all	groups	showing	a	similar	desire	to	quit	which	has	not	changed	since	2000	(apart	
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from	an	apparent	small	decline	in	those	with	longstanding	mental	illness	between	2006	and	2009,	
which	appears	to	be	increasing	again	since	then).		
	
There	are	some	limitations	with	the	HSE	data	analysed	in	this	study.	From	the	questions	asked	of	
survey	respondents	and	the	resulting	data	available	it	is	not	possible	to	say	in	any	detail	what	type	of	
mental	health	disorder	an	individual	has,	or	whether	a	respondent’s	reported	condition	has	been	
confirmed	as	a	clinical	disorder	by	professionals.	The	two	indicators	are	likely	capturing	different	
types	of	mental	disorder	given	the	discrepancy	between	the	proportions	reporting	positively	to	the	
two	questions.	A	more	comprehensive	set	of	questions	assessing	specific	serious	mental	health	
disorders	would	have	been	preferable	to	the	questions	asked	in	the	HSE.	However,	national	
psychiatric	morbidity	surveys	are	carried	out	infrequently	(in	England,	about	every	seven	years)	and	
therefore	the	data	are	insufficient	for	assessing	trends	over	time.	Few	annual	national	smoking	
surveys	assess	mental	health	adequately.	We	recommend	that	researchers	advocate	for	the	
inclusion	of	improved	questions	in	national	smoking	surveys	in	the	future.	In	addition,	as	mentioned	
previously	the	small	number	of	survey	participants	with	the	indicators	of	mental	health	used	here	
limits	the	power	to	generate	accurate	estimates	for	each	year.	Indeed,	the	estimate	of	smoking	
prevalence	in	those	taking	a	psychoactive	medication	in	2009	may	be	an	outlier	(Figure	1a),	making	
it	difficult	to	judge	whether	prevalence	in	this	group	has,	in	fact,	been	in	decline	since	approximately	
2003.	The	linear	regression	approach	we	have	used	to	generate	estimates	of	percentage	changes	in	
each	outcome	per	year	does	not	take	into	account	the	error	around	each	annual	estimate.	However,	
our	conclusions	are	unchanged	when	data	are	analysed	using	a	logistic	model.	
	
The	2007	Adult	Psychiatric	Morbidity	Survey	(APMS)	reports	a	prevalence	of	17.8%	of	any	mental	
disorder,	though	for	a	number	of	specific	conditions,	including	depression	and	anxiety,	respondents	
are	only	asked	whether	they	have	been	affected	over	the	past	week	(Royal	College	of	Physicians	and	
Royal	College	of	Psychiatrists,	2013);	this	makes	comparison	with	the	HSE	estimates	of	longstanding	
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mental	disorder	difficult.	A	study	using	national	general	practitioner	data	found	a	much	higher	
prevalence	(14%)	of	psychoactive	medication	usage	at	any	point	over	the	course	of	a	year	
(Szatkowski	and	McNeill,	2013)	than	the	prevalence	of	current	psychoactive	medication	use	
captured	by	the	HSE	survey	(which	asks	about	medication	use	within	the	seven	days	prior	to	
interview).	A	significantly	higher	smoking	prevalence	was	observed	in	those	using	psychoactive	
medication	in	these	general	practitioner	data	(Szatkowski	and	McNeill,	2013)	and	we	have	no	reason	
to	believe	that	there	would	be	a	difference	in	trends	in	smoking	prevalence	between	this	larger	
group	of	medication	users	and	our	smaller	sample.	
	
The	proportion	of	survey	respondents	self-reporting	a	longstanding	mental	health	condition	has	
increased	over	time,	which	may	reflect	a	greater	willingness	to	report	such	problems	rather	than	a	
true	increase	in	their	prevalence.	Thus,	the	characteristics	of	the	patients	identified	as	having	a	
longstanding	mental	health	condition	may	have	changed	over	time	and,	if	these	characteristics	are	
also	related	to	smoking	behaviour,	this	may	confound	assessment	of	longitudinal	trends	in	smoking	
prevalence,	cigarette	consumption	and	desire	to	quit.	Similarly,	propensity	to	report	smoking	may	
have	changed	over	time,	particularly	as	the	behaviour	has	become	less	socially	acceptable.		
	
As	a	household	survey	the	HSE	excludes	those	with	mental	disorders	who	are	not	living	in	the	
community.	People	with	the	most	severe	mental	illness	may	be	living	in	inpatient	healthcare	
institutions,	or	perhaps	in	other	settings	such	as	prisons	and	temporary	housing,	or	be	homeless.	
These	groups	are	also	known	to	have	a	higher	smoking	prevalence	and	the	HSE	may,	therefore,	
underestimate	the	population	prevalence	of	mental	illness	and	smoking.	
	
The	disparity	between	the	proportion	of	survey	respondents	reporting	the	use	of	psychoactive	
medication	and	those	reporting	a	longstanding	mental	health	condition	indicates	some	complexities	
related	to	these	measures	of	mental	disorder.	Certain	psychoactive	medications	are	commonly	
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prescribed	for	the	treatment	of	somatic	rather	than	psychiatric	conditions	(e.g.	antidepressants	for	
chronic	pain),	and	thus	patients	taking	these	drugs	may	not	report	themselves	as	having	a	
longstanding	mental	condition.	However,	we	included	this	measure	for	completion	as	some	people	
with	a	mental	health	condition	might	not	have	classified	their	illness	as	‘long-standing	mental	illness,	
depression	or	anxiety’.	
	
Our	findings	are	in	line	with	those	from	America	reported	recently	(Lê	Cook	et	al.,	2014;	New	York	
State	Department	of	Health,	2012).	Further	work	is	needed	to	understand	the	reasons	for	the	
persisting	high	smoking	prevalence	and	daily	cigarette	consumption	in	smokers	with	mental	
disorder.	These	figures	may	be	driven	by	different	patterns	of	smoking	uptake	and/or	cessation	in	
smokers	with	mental	disorder	compared	to	those	without.	Given	that	smokers	both	with	and	
without	a	longstanding	mental	health	condition	report	similar	levels	of	desire	to	quit	smoking	
altogether,	similar	to	findings	reported	previously	(Siru,	Hulse	&	Tait,	2009),	it	may	be	that	there	are	
barriers	to	cessation	in	smokers	with	mental	disorders.	One	possible	explanation	is	that	these	
smokers	receive	cessation	interventions	less	frequently	during	routine	primary	health	care	
consultations	than	smokers	without	mental	disorders,	which	may	translate	into	lower	quit	rates	
(Szatkowski	&	McNeill,	2013).	
	
Figure	1	suggests	that	the	fastest	rate	of	decline	in	smoking	prevalence	and	daily	cigarette	
consumption	in	those	who	do	not	report	a	longstanding	mental	health	condition	has	occurred	since	
the	start	of	the	21st	Century.	A	number	of	tobacco	control	measures	have	been	introduced	in	
England	over	this	time	period,	including	the	addition	of	graphic	health	warnings	to	cigarette	
packaging,	establishment	of	specialist	cessation	services,	pricing	policies,	as	well	as	the	introduction	
of	smokefree	legislation.	Such	policies	may	have	altered	patterns	of	smoking,	and	smokers	with	
indicators	of	mental	disorder	may	not	have	responded	in	the	same	way	to	this	changing	policy	
environment	as	smokers	without	these	indicators.	Again,	further	work	is	warranted	to	investigate	
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any	differential	impact	of	policies.	Improved	knowledge	is	vital	to	enable	appropriate	measures	to	be	
taken	to	reduce	smoking	in	those	with	mental	disorders	and	so	reduce	widening	health	inequalities	
caused	by	their	persistent	smoking	patterns.		
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Figure	1:	Temporal	trends	in	smoking	behvaiours	according	to	self-reported	mental	health	status	and	
psychoactive	drug	use	(bars	indicate	95%	confidence	intervals)		
	
a)	Smoking	prevalence	
	 	
	
b)	Average	daily	cigarette	consumption		
	 	
	
c)	Desire	to	quit	
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Table	1:	Annual	absolute	%	changes	in	smoking	behaviours	in	respondents	reporting	and	not	reporting	a	longstanding	mental	health	disorder	or	currently	
taking	a	psychoactive	medication	
Respondents	not	reporting	
a	mental	health	condition	
(%	change,	95%	CI)	
Respondents	reporting	a	
mental	health	condition	
(%	change,	95%	CI)	
Respondents	not	reporting	
taking	a	psychoactive	
medication	
(%	change,	95%	CI)	
Respondents	reporting	
taking	a	psychoactive	
medication	
(%	change,	95%	CI)	
Smoking	prevalence	 -0.48	(-0.56	to	-0.40)**		 -0.07	(-0.33	to	0.20)		 -0.53	(-0.61	to	-0.44)**	 -0.32	(-0.54-	to	-0.10)*	
Average	daily	cigarette		consumption	 -0.14	(-0.17	to	-0.11)**	 -0.03	(-0.12	to	0.07)		 -0.16	(-0.19--0.12)**		 -0.03	(-0.12	to	0.05)		
Proportion	of	smokers	reporting	
wanting	to	quit	(from	2000)	 -0.24	(-0.56	to	0.09)	 -0.89	(-1.86	to	0.08)	 -0.29	(-0.67	to	0.09)		 -0.06	(-0.71	to	0.59)		
*p<0.05	**p<0.001	
	
 
